No photo of Peter Thompson

View Scopus Profile

Peter Thompson

Clinical Professor

  • The University of Western Australia (M503), 35 Stirling Highway,

    6009 Perth

    Australia

  • 2789 Citations
  • 29 h-Index
20012019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Peter Thompson is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 41 Similar Profiles
Coronary Disease Medicine & Life Sciences
Population Medicine & Life Sciences
Carotid Artery Diseases Medicine & Life Sciences
Acute Coronary Syndrome Medicine & Life Sciences
Hydroxymethylglutaryl-CoA Reductase Inhibitors Medicine & Life Sciences
Myocardial Infarction Medicine & Life Sciences
Pravastatin Medicine & Life Sciences
Cardiovascular Diseases Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2001 2019

Changes in plasma lipids predict pravastatin efficacy in secondary prevention

LIPID Study Investigators, 11 Jul 2019, In : JCI Insight. 4, 13, 13 p., 128438.

Research output: Contribution to journal › Article

4 Citations (Scopus)

Colchicine in Cardiovascular Disease: Repurposing an Ancient Gout Drug

Thompson, P. L., 1 Jan 2019, In : Clinical Therapeutics. 41, 1, p. 8-10 3 p.

Research output: Contribution to journal › Editorial

4 Citations (Scopus)

Anti-inflammatory therapy with canakinumab for atherosclerotic disease: Lessons from the CANTOS trial

Thompson, P. L. & Mark Nidorf, S., 1 Feb 2018, In : Journal of Thoracic Disease. 10, 2, p. 695-698 4 p.

Research output: Contribution to journal › Editorial

2 Citations (Scopus)

Colchicine: an affordable anti-inflammatory agent for atherosclerosis

Thompson, P. L. & Nidorf, S. M., 1 Dec 2018, In : Current Opinion in Lipidology. 29, 6, p. 467-473 7 p.

Research output: Contribution to journal › Article

Colchicine
Interleukin-1
Atherosclerosis
Anti-Inflammatory Agents
Inflammation
9 Citations (Scopus)

Large-scale plasma lipidomic profiling identifies lipids that predict cardiovascular events in secondary prevention

LIPID Study Investigators, 6 Sep 2018, In : JCI Insight. 3, 17, e121326.

Research output: Contribution to journal › Article

Secondary Prevention
Lipids
Omega-6 Fatty Acids
Myocardial Infarction
Government Programs

Projects 2003 2019

MHRIF Round 21 - Peter Thompson

Thompson, P.

WA Department of Health

1/01/18 → 31/12/18

Project: Research

MHRIF Round 20 - Peter Thompson

Thompson, P.

WA Department of Health

1/01/17 → 31/12/17

Project: Research

Vanguard Grant - Low Dose Colchicine After Acute Myocardial Infarction - LoDoCo MI

Hillis, G., Thompson, P., Chow, C. & Brieger, D.

National Heart Foundation

1/04/15 → 31/03/16

Project: Research

LoDoCo2 Low Dose Colchicine for secondary prevention in Stable Coronary Heart Disease (the LoDoCo2 Trial)

Thompson, P., Nidorf, S. & Eikelboom, J.

National Health & Medical Research Council NHMRC

1/01/15 → 31/12/19

Project: Research

Merit Award - Projects - A Randomised Controlled Trial of Vitamin D Replacement on Cardiovascular Disease Risk in Vitamin D Deficient Chronic Kidney Disease Patients

Lim, W., Prince, R., Thompson, P., Lewis, J. & Coates, P.

WA Department of Health

1/07/14 → 30/06/15

Project: Research